Show Notes
Kevin is the co-Founder of Delphi Digital, a leading crypto research firm. We talk about his Bitcoin 4 year cycle prediction which has played out perfectly. What does the outlook & indicators show for the rest of 2024, how you can use this model, global liquidity, macro update, what factors to watch out for, inflation, how presidential cycles affect the market, and more.
Thank you for tuning in. If you can spare 5 seconds to leave a review/rating on iTunes, I appreciate it. If you share the show on Twitter I'll reply everytime! 🔥
This episode is brought to you by Mantle Network, an Ethereum L2 backed by a $4.4 billion treasury, one of the largest in the industry. Recently, Mantle has emerged as one of the most popular L2 who offering the most rewarding opportunities. Go checkout the Mantle Rewards Station today to start earning rewards from top projects like Ethena or Eigen Layer. Earn rewards INSTANTLY. Visit the Mantle Rewards Station here: https://www.mantle.xyz/rewards-station
More from Convergence
Alex Colville, PhD, is co-founder and General Partner of age1, the first longevity-focused venture fund, which he started with Laura Deming. He studied the biology of aging for his PhD in Genetics at Stanford and previously managed more than $100 million in longevity investments and philanthropy. Why the ChatGPT moment for aging is closer than you think. Alex explains why longevity is exploding now, most exciting areas to invest for biotech, stem cells, epigenetic reprogramming, reversible cryopreservation, NewLimit's big bet, whether one cure exists, peptides, AI in biotech, zero-person biotechs, why AI labs are becoming biotechs, open source vs. secrecy, crypto founders' longevity bets, the story behind age1, moonshots, helping dogs live longer, a Manhattan Project for aging, and the one bet he'd make today. ━━━━━━━━━━━━━━━━━━━━ Thank you for tuning in. If you can spare 5 seconds to leave a review/rating on iTunes or Spotify. It helps grow the show so I can continue to host great guests. ━━━━━━━━━━━━━━━━━━━━ This episode is brought to you by Kraken by Payward. Get Kraken and use code CONVERGENCE1000 to unlock a $1,000 funded account once you pass the challenge at https://www.kraken.com/features/funded Disclaimer: Terms apply. Not investment advice. Crypto trading involves risk of loss and is offered to US customers through Payward Interactive, Inc. View legal disclosures at kraken.com/legal/disclosures. Securities and brokerage services offered by Kraken Securities LLC, member FINRA/SIPC. Digital asset services offered by Payward Interactive Inc., (NMLS ID:1843762) a FINCEN registered money services business, not a member of FINRA/SIPC and not FDIC insured. Kraken Funded is an unregulated service. Funded traders onboard with Payward Oceanic Ltd. Evaluation fees apply and are non-refundable for each attempt once trading begins, regardless of outcome. Availability varies by jurisdiction. ━━━━━━━━━━━━━━━━━━━━ (00:00) Intro (01:45) Chatgpt Moment for Biotech (03:57) Why Longevity Is Exploding Now (07:33) Delay, Replace, Pause, Reverse (11:09) Growing Fresh Cells From Stem Cells (16:07) Epigenetic Reprogramming (19:50) Sponsored by Kraken (20:56) Reversible Cryopreservation (22:56) NewLimit's Big Bet (28:15) Is There One Cure? (30:10) Peptides Real or Hype? (34:30) What AI Is Unlocking in Biotech (36:54) Zero-Person Biotech? (40:35) Ai Labs Becoming Biotechs (44:06) Open Source vs Secrecy (47:18) Crypto Founders Longevity Bets (50:05) The Story Behind Age1 (55:30) Moonshots (1:00:55) Dogs Living Forever (1:03:31) Manhattan Project for Aging (1:06:38) Contrarian Biotech (1:09:07) Holy Grail Bet ━━━━━━━━━━━━━━━━━━━━ Convergence is produced by DELPHI MEDIA, LLC, a member of the DELPHI DIGITAL family of companies. This content is solely for educational and informational purposes and is not, and should not be construed as, legal, tax, investment, or financial advice. Delphi is not a financial, tax, or legal advisor. You are expressly advised to consult with a professional advisor before making any investment decisions. Also, the views expressed by Podcast guests do not necessarily reflect those of Delphi.
Nic Carter is an investor, Founding Partner at Castle Island Ventures, previously founded Coin Metrics, and researcher.
Guests: Daniel Matuszewski is Co-Founder at CMS Holdings, one of the industry's more prolific funds. Zaheer Ebtikar is the Chief Investment Officer and founder of Split Capital, a hedge fund specializing in liquid token investments. This episode is a deep dive into the circumstances that led to the cascading liqudiation selloff on Oct 10th, what it means moving forward, why this will happen again, bearwhale shortseller, alts vs BTC, cycle inflection points, new launches in Q4, altcoin ETFs, too many coins thesis, and more... Thank you for tuning in. If you can spare 5 seconds to leave a review/rating on iTunes, I appreciate it. If you share the show on Twitter, I'll reply everytime! 🔥
Guest: Travis Kling is the CIO at Ikigai Asset Management, a crypto hedge fund. In this episode we discuss his 3 part thesis for 2024 which went viral after it accurately predicted how strange crypto would behave this cycle. We explore financial nihilism, the rise of memecoins, billions of dollars in FTX redemptions hitting the market, Bitcoin seperating itself from everything else, how the presidential election will impact prices, which sectors could emerge as the new meta, quiet quitting, and more.
Crash (@CrashiusClay69) is one of most successful memecoin traders this bull cycle & has gained a loyal following of over 120k people who follow his analysis for new coins, trades, or themes to watch. We discuss how he finds big wins early, making his first million, the mental battle of trading, knowing when to sell, Base vs Solana, his personal strategy, top picks, and more.